Log in to save to my catalogue

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_316415

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

About this item

Full title

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2017, Vol.127 (1), p.153-168

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Most patients who initially respond to treatment with the multi-tyrosine kinase inhibitor sunitinib eventually relapse. Therefore, developing a deeper understanding of the contribution of sunitinib's numerous targets to the clinical response or to resistance is crucial. Here, we have shown that cancer cells respond to clinically relevant doses of s...

Alternative Titles

Full title

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_316415

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_316415

Other Identifiers

ISSN

0021-9738,1558-8238

E-ISSN

1558-8238

DOI

10.1172/JCI84386

How to access this item